FIN
18/12/2014 11:34
SSH
PRICE SENSITIVE
REL: 1134 HRS Finzsoft Solutions Limited
SSH: FIN: SSH Notice - Holliday Group Holdings (ICT Investments) Ltd
DISCLOSURE OF MOVEMENT OF 1% OR MORE IN SUBSTANTIAL HOLDING OR CHANGE IN
NATURE OF RELEVANT INTEREST OR BOTH
Sections 277 and 278, Financial Markets Conduct Act 2013
TO: NZX Limited
and
TO: Finzsoft Solutions Limited ("FIN")
Relevant event being disclosed: Change in nature of relevant interest
Date of relevant event: 18 December 2014
Date this disclosure made: 18 December 2014
Date last disclosure made: 21 November 2013
Substantial product holder(s) giving disclosure
Full name(s): Holliday Group Holdings (ICT Investments) Limited ("HGH")
Summary of substantial holding
Class of quoted voting products: Ordinary shares
Summary for: HGH
For this disclosure:
(a) total number held in class: 5,646,438
(b) total in class: 8,566,163
(c) total percentage held in class: 65.916%
For last disclosure:
(a) total number held in class: 5,646,438
(b) total in class: 8,314,000
(c) total percentage held in class: 67.915%
Details of transactions and events giving rise to relevant event
Details of the transactions or other events requiring disclosure: On 18
December 2014, HGH entered into a lock-up agreement with Silverlake HGH
Limited in relation to a proposed full takeover offer for all of the equity
securities of FIN. Under that agreement, Silverlake HGH Limited has agreed,
subject to the provisions of the agreement, to make a full takeover offer for
all of the equity securities in FIN, and HGH has agreed to accept that offer
in respect of its holding of 5,646,438 shares in FIN.
Details after relevant event
Details for: HGH
Nature of relevant interest(s): Registered holder and beneficial owner of
financial products subject to the lock-up agreement (attached as document A,
24 pages)
For that relevant interest:
(a) number held in class: 5,646,438
(b) percentage held in class: 65.916%
(c) current registered holder(s): HGH
(d) registered holder(s) once transfers are registered: Silverlake HGH
Limited
Additional information
Address(es) of substantial product holder(s): 22 Winscombe Street, Belmont,
Auckland, 0622
Contact details: Andrew Holliday
Phone: +64 21 355 492
Email: [email protected]
Name of any other person believed to have given, or believed to be required
to give, a disclosure under the Financial Markets Conduct Act 2013 in
relation to the financial products to which this disclosure relates:
Silverlake HGH Limited
Certification
I, Andrew Alexander Holliday, certify that, to the best of my knowledge and
belief, the information contained in this disclosure is correct and that I am
duly authorised to make this disclosure by all persons for whom it is made.
End CA:00259095 For:FIN Type:SSH Time:2014-12-18 11:34:16